chr20-610047-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004609.4(TCF15):c.191G>A(p.Gly64Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000231 in 1,126,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G64S) has been classified as Uncertain significance.
Frequency
Consequence
NM_004609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TCF15 | NM_004609.4 | c.191G>A | p.Gly64Asp | missense_variant | 1/2 | ENST00000246080.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TCF15 | ENST00000246080.4 | c.191G>A | p.Gly64Asp | missense_variant | 1/2 | 1 | NM_004609.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000137 AC: 2AN: 146210Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000245 AC: 24AN: 979712Hom.: 0 Cov.: 49 AF XY: 0.0000174 AC XY: 8AN XY: 460768
GnomAD4 genome AF: 0.0000137 AC: 2AN: 146310Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 71256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.191G>A (p.G64D) alteration is located in exon 1 (coding exon 1) of the TCF15 gene. This alteration results from a G to A substitution at nucleotide position 191, causing the glycine (G) at amino acid position 64 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at